Exam (elaborations)
Radiopharmaceuticals (with complete solutions)
- Course
- Institution
Y-90 ibritumomab tiuxetan correct answers Yttrium-90 ibritumomab tiuxetan Indicated for the: • Treatment of relapsed or refractory, low-grade or follicular B-cell non-Hodgkin's lymphoma (NHL) • Treatment of previously untreated follicular NHL in patients who achieve a partial or complete res...
[Show more]